Description
PRIMOROW 100 mg/10 ml Vial (Methenolone Enanthate)
PRIMOROW 100 mg/10 ml Vial contains Methenolone Enanthate, a mild yet effective anabolic steroid, known for its ability to promote lean muscle retention during cutting cycles. Prized for its ability to help athletes and bodybuilders maintain muscle mass while reducing body fat, making it ideal for those looking to achieve a more defined, vascular physique.
Methenolone Enanthate has a relatively low risk of side effects compared to stronger anabolic steroids, which makes it a popular choice for those new to steroid use or those seeking to avoid common issues like water retention or excessive estrogenic effects. Its mild nature means it does not significantly affect natural testosterone production, making post-cycle therapy (PCT) less intense compared to other steroids.
How It Works
Methenolone Enanthate enhances nitrogen retention and protein synthesis, aiding in preserving muscle mass during calorie deficits. Its long ester ensures a sustained release, requiring fewer injections while maintaining consistent blood levels.
Proper Use and Dosage
A typical dosage ranges from 200-400 mg per week for men and 50-100 mg per week for women. Injections are administered intramuscularly, usually once or twice weekly, depending on the cycle structure.
Benefits
PRIMOROW supports lean muscle retention, enhances strength, and promotes a hard, defined physique. It has minimal androgenic effects and does not aromatize, making it ideal for athletes seeking quality muscle gains.
Side Effects
Side effects are rare but may include mild suppression of natural testosterone, acne, or hair thinning in predisposed individuals. Post-cycle therapy is advised to restore hormonal balance after use.
Where to buy
Whenever bodybuilders want to buy steroids online and a reliable source, it’s always expected that the steroids shop they buy from – Finest Gears, for example – has the products they desire.
1 review for PRIMOROW 100 mg/10 ml Vial (Methenolone Enanthate)
There are no reviews yet.